John Newell‐Price

22.3k total citations · 9 hit papers
168 papers, 12.4k citations indexed

About

John Newell‐Price is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, John Newell‐Price has authored 168 papers receiving a total of 12.4k indexed citations (citations by other indexed papers that have themselves been cited), including 147 papers in Endocrinology, Diabetes and Metabolism, 52 papers in Surgery and 21 papers in Molecular Biology. Recurrent topics in John Newell‐Price's work include Pituitary Gland Disorders and Treatments (117 papers), Adrenal Hormones and Disorders (87 papers) and Adrenal and Paraganglionic Tumors (48 papers). John Newell‐Price is often cited by papers focused on Pituitary Gland Disorders and Treatments (117 papers), Adrenal Hormones and Disorders (87 papers) and Adrenal and Paraganglionic Tumors (48 papers). John Newell‐Price collaborates with scholars based in United Kingdom, United States and Italy. John Newell‐Price's co-authors include Lynnette K. Nieman, Ashley Grossman, James W. Findling, Beverly M. K. Biller, Martin O. Savage, Xavier Bertagna, Paul M. Stewart, Víctor M. Montori, Peter Trainer and Antoine Tabarin and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

In The Last Decade

John Newell‐Price

158 papers receiving 12.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline

2008 1.8k citations Beverly M. K. Biller, John Newell‐Price et al. The Journal of Clinical Endocrinology & Metabolism profile →
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors

2016 996 citations Martin Faßnacht, Wiebke Arlt et al. European Journal of Endocrinology profile →
Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement

2003 963 citations A. B. Atkinson, Ashley Grossman et al. The Journal of Clinical Endocrinology & Metabolism profile →
Cushing's syndrome

2006 837 citations John Newell‐Price, Ashley Grossman et al. profile →
Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline

2015 774 citations Beverly M. K. Biller, John Newell‐Price et al. The Journal of Clinical Endocrinology & Metabolism profile →
The Diagnosis and Differential Diagnosis of Cushing’s Syndrome and Pseudo-Cushing’s States

1998 570 citations John Newell‐Price, Peter Trainer et al. profile →
A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease

2012 442 citations Stephan Petersenn, John Newell‐Price et al. profile →
Complications of Cushing's syndrome: state of the art

2016 402 citations Rosario Pivonello, John Newell‐Price et al. The Lancet Diabetes & Endocrinology profile →
European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors

2023 261 citations Martin Faßnacht, Stylianos Tsagarakis et al. European Journal of Endocrinology profile →

Peers

Countries citing papers authored by John Newell‐Price

Since Specialization

Citations

This map shows the geographic impact of John Newell‐Price's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Newell‐Price with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Newell‐Price more than expected).

Fields of papers citing papers by John Newell‐Price

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Newell‐Price. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Newell‐Price. The network helps show where John Newell‐Price may publish in the future.

Co-authorship network of co-authors of John Newell‐Price

This figure shows the co-authorship network connecting the top 25 collaborators of John Newell‐Price. A scholar is included among the top collaborators of John Newell‐Price based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Newell‐Price. John Newell‐Price is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Etomidate in Severe Cushing Syndrome: A Systematic Review 2025 ·Journal of the Endocrine Society ·(unknown), (unknown), (unknown), Pasyodun Koralage Buddhika Mahesh, (unknown), (unknown), (unknown), John Newell‐Price	2
2	Long-term outcomes in patients with congenital adrenal hyperplasia treated with hydrocortisone modified-release hard capsules 2025 ·European Journal of Endocrinology ·Wiebke Arlt, Aude Brac de la Perrière, Angelica Lindén Hirschberg, Deborah P. Merke, John Newell‐Price, Alessandro Prete, Aled Rees, Nicole Reisch, Philippe Touraine, (unknown), John M. Porter, (unknown), Richard Ross	3
3	Osilodrostat dose impact on efficacy/safety in Cushing's disease: large, pooled analysis of LINC 2, 3, and 4 2025 ·European Journal of Endocrinology ·Maria Fleseriu, Rosario Pivonello, André Lacroix, Beverly M. K. Biller, Richard A. Feelders, Mônica R. Gadelha, Jérôme Bertherat, Zhanna Belaya, (unknown), Alberto M Pedroncelli, John Newell‐Price	1
4	6907 Continued Improvements in Hypertension and Diabetes During Long-Term Osilodrostat Therapy in Patients with Cushing’s Disease: A Pooled Analysis from the Phase III LINC 3 and LINC 4 Studies 2024 ·Journal of the Endocrine Society ·Maria Fleseriu, Rosario Pivonello, John Newell‐Price, Mônica R. Gadelha, Richard J. Auchus, Richard A. Feelders, André Lacroix, (unknown), Przemysław Witek, M Bex, (unknown), Alberto M Pedroncelli, Beverly M. K. Biller	1
5	A Retrospective Study on Weaning Glucocorticoids and Recovery of the Hypothalamic–Pituitary–Adrenal Axis 2024 ·The Journal of Clinical Endocrinology & Metabolism ·(unknown), Charlotte Elder, John Newell‐Price, Richard Ross, Miguel Debono	4
6	Improvement in clinical features of hypercortisolism during osilodrostat treatment: findings from the Phase III LINC 3 trial in Cushing's disease 2024 ·Journal of Endocrinological Investigation ·Rosario Pivonello, Maria Fleseriu, John Newell‐Price, Akira Shimatsu, Richard A. Feelders, Pınar Kadıoğlu, Antoine Tabarin, Thierry Brue, Eliza B. Geer, (unknown), Alberto M Pedroncelli, Beverly M. K. Biller	6
7	Improved Clinical Outcomes During Long-term Osilodrostat Treatment of Cushing Disease With Normalization of Late-night Salivary Cortisol and Urinary Free Cortisol 2024 ·Journal of the Endocrine Society ·John Newell‐Price, Maria Fleseriu, Rosario Pivonello, Richard A. Feelders, Mônica R. Gadelha, André Lacroix, (unknown), Anthony P. Heaney, (unknown), Alberto M Pedroncelli, Beverly M. K. Biller	6
8	Comparison of modified-release hydrocortisone capsules versus prednisolone in the treatment of congenital adrenal hyperplasia 2024 ·Endocrine Connections ·Aled Rees, Deborah P. Merke, Wiebke Arlt, Aude Brac de la Perrière, Angelica Lindén Hirschberg, Anders Juul, John Newell‐Price, Alessandro Prete, Nicole Reisch, Nike Stikkelbroeck, Philippe Touraine, (unknown), John M. Porter, (unknown), Richard Ross	2
9	Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis 2023 ·European Journal of Endocrinology ·Iris C. M. Pelsma, Martin Faßnacht, Stylianos Tsagarakis, Massimo Terzolo, Antoine Tabarin, Anju Sahdev, John Newell‐Price, Ljiljana Marina, Kerstin Lorenz, Irina Bancos, Wiebke Arlt, Olaf M. Dekkers	47
10	THU041 Clinical Improvements In Patients With Cushing’s Disease Treated With Osilodrostat According To Urinary And Late-night Salivary Cortisol Levels: Pooled Analysis From LINC 3 And LINC 4 2023 ·Journal of the Endocrine Society ·Beverly M. K. Biller, Maria Fleseriu, Rosario Pivonello, Richard A. Feelders, Mônica R. Gadelha, André Lacroix, Przemysław Witek, Anthony P. Heaney, (unknown), Alberto M Pedroncelli, John Newell‐Price	1
11	Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group to Consider Renaming Diabetes Insipidus 2022 ·Hormone Research in Paediatrics ·Hiroshi Arima, Timothy Cheetham, Mirjam Christ‐Crain, (unknown), Juliana Drummond, Mark Gurnell, Miles Levy, Ann McCormack, John Newell‐Price, Joseph G. Verbalis, John Wass	2
12	Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus 2022 ·Archives of Endocrinology and Metabolism ·Hiroshi Arima, Timothy Cheetham, Mirjam Christ‐Crain, (unknown), Juliana Drummond, Mark Gurnell, Miles Levy, Ann McCormack, John Newell‐Price, Joseph G. Verbalis, John Wass	3
13	Central diabetes insipidus from a patient's perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey 2022 ·The Lancet Diabetes & Endocrinology ·Cihan Atila, (unknown), Aoife Garrahy, Bettina Winzeler, Julie Refardt, (unknown), (unknown), Aparna Pal, Joseph G. Verbalis, Christopher J. Thompson, Lars G. Hemkens, Steven Hunter, Mark Sherlock, Miles Levy, Niki Karavitaki, John Newell‐Price, John Wass, Mirjam Christ‐Crain	37
14	Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus 2022 ·Endocrine Journal ·(unknown), Hiroshi Arima, Timothy Cheetham, Mirjam Christ‐Crain, (unknown), Mark Gurnell, Juliana Drummond, Miles Levy, Ann McCormack, Joseph G. Verbalis, John Newell‐Price, John Wass	6
15	Long‐term efficacy and safety of once‐monthly pasireotide in Cushing's disease: A Phase III extension study 2019 ·Clinical Endocrinology ·Maria Fleseriu, Stephan Petersenn, Beverly M. K. Biller, Pınar Kadıoğlu, Christophe De Block, Guy T’Sjoen, Marie‐Christine Vantyghem, Libuse Tauchmanovà, (unknown), Sy Ha, André Lacroix, John Newell‐Price	29
16	Adrenocortical incidentalomas and bone: from molecular insights to clinical perspectives 2018 ·Endocrine ·Barbara Altieri, Giovanna Muscogiuri, Stavroula Α. Paschou, Andromachi Vryonidou, Silvia Della Casa, Alfredo Pontecorvi, Martin Faßnacht, Cristina L. Ronchi, John Newell‐Price	11
17	Effective Combination Treatment with Cabergoline and Low-Dose Pegvisomant in Active Acromegaly: A Prospective Clinical Trial 2012 ·The Journal of Clinical Endocrinology & Metabolism ·Claire Higham, A. B. Atkinson, Simon Aylwin, Martin Bidlingmaier, William Drake, A A M Lewis, Niamh Martin, (unknown), John Newell‐Price, Peter Trainer	76
18	Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy 2009 ·European Journal of Endocrinology ·Miguel Debono, Richard Ross, John Newell‐Price	101
19	The differential diagnosis of Cushing's syndrome. 2001 ·PubMed ·John Newell‐Price, Ashley Grossman	7
20	Desmopressin Normalizes the Blunted Adrenocorticotropin Response to Corticotropin-Releasing Hormone in Melancholic Depression: Evidence of Enhanced Vasopressinergic Responsivity 1999 ·The Journal of Clinical Endocrinology & Metabolism ·Timothy G. Dinan, (unknown), Lucinda V. Scott, John Newell‐Price, Sami Medbak, (unknown)	53

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact